首页|期刊导航|中国医药科学|经鼻高流量湿化氧疗在缺血性脑卒中患者中应用效果的meta分析

经鼻高流量湿化氧疗在缺血性脑卒中患者中应用效果的meta分析OA

Meta-analysis of the application effect of high-flow oxygen through nasal cannula in patients with ischemic stroke

中文摘要英文摘要

目的 对经鼻高流量湿化氧疗(HFNC)在缺血性脑卒中患者中的应用效果进行meta分析.方法 检索中国知网、万方、维普、PubMed、Web of Science、Embase、Cochrane Library数据库中关于HFNC在缺血性脑卒中患者中应用的随机对照试验(RCT),检索时限为自建库至 2023 年 12 月 31 日,并对纳入文献的参考文献进行引证检索.由 2 名研究者独立进行文献筛选、数据提取和质量评价,采用RevMan 5.3 软件进行数据分析,合并效应统计量采用标准化均数差(SMD)或相对危险度(RR)及95%置信区间(95%CI)表示.结果 共纳入文献 8 篇,共 851 例患者.A级文献 1 篇,B级文献 7 篇.meta分析结果显示HFNC组和对照组患者在动脉血氧分压(PaO2)[SMD=1.29,95%CI(0.69,1.89),P<0.0001]、动脉血氧饱和度(SaO2)[SMD=0.97,95%CI(0.13,1.81),P=0.02]、氧合指数[SMD=0.62,95%CI(0.41,0.82),P<0.000 01]、呼吸频率[SMD=-1.21,95%CI(-1.77,-0.65),P<0.0001]、心率[SMD=-1.11,95%CI(-1.85,-0.37),P=0.003]、气管插管率[RR=0.49,95%CI(0.35,0.68),P<0.0001]、ICU住院时间[SMD=-2.85,95%CI(-4.50,-1.20),P=0.0007]方面差异有统计学意义;在动脉血二氧化碳分压(PaCO2)[SMD=-0.60,95%CI(-1.29,0.08),P=0.08]、病死率[RR=0.97,95%CI(0.50,1.85),P=0.92]方面差异无统计学意义.结论 HFNC可以提高患者的PaO2 和SaO2,改善氧合指数,稳定呼吸频率和心率,缩短ICU住院时间,降低气管插管率.但是纳入研究质量中等,未来仍需更多高质量、多中心的RCT进行验证.

Objective To conduct a meta-analysis on the application effect of high-flow oxygen through nasal cannula(HFNC)in patients with ischemic stroke.Methods Randomized controlled trials(RCTs)and quasi trials on the application of HFNC in ischemic stroke patients were retrieved from databases such as CNKI,Wanfang,VIP,PubMed,Web of Science,Embase,and Cochrane Library,with the search period spanning from the inception of each database to December 31,2023.Additionally,reference lists of included studies were manually searched.Two researchers independently conducted literature screening,data extraction,and quality evaluation,using RevMan 5.3 software for data analysis.The combined effect statistic was represented by standardized mean difference(SMD),relative risk(RR),and 95%confidence interval(CI).Results A total of 8 articles and 851 patients were ultimately included in the study.1 A-level literature and 7 B-level literature.The meta-analysis results showed that patients in the HFNC group and the control group had differences in arterial oxygen partial pressure(PaO2)(SMD=1.29,95%CI[0.69,1.89],P<0.0001),arterial oxygen saturation(SaO2)(SMD=0.97,95%CI[0.13,1.81],P=0.02),oxygenation index(SMD=0.62,95%CI[0.41,0.82],P<0.000 01),respiratory rate(SMD=-1.21,95%CI[-1.77,-0.65],P<0.0001),heart rate(SMD=-1.11,95%CI[-1.85,-0.37],P=0.003),tracheal intubation rate(RR=0.49,95%CI[0.35,0.685],P<0.0001)and ICU length of stay(SMD=-2.85,95%CI[-4.50,-1.20],P=0.0007).There was no statistically significant difference in arterial partial pressure of carbon dioxide(PaCO2)(SMD=-0.60,95%CI[-1.29,0.08],P=0.08),and mortality rate(RR=0.97,95%CI[0.50,1.85],P=0.92).Conclusion HFNC can increase patients'PaO2 and SaO2,improve oxygenation index,stabilize respiratory rate and heart rate,shorten ICU stay,and reduce tracheal intubation.However,the quality of the included studies is moderate,and more high-quality,multicenter RCTs are still needed for validation in the future.

韩明月;刘雪芳;王桂华;苗凤茹

航天中心医院神经内科,北京 100049航天中心医院神经内科,北京 100049航天中心医院神经内科,北京 100049航天中心医院神经内科,北京 100049

医药卫生

经鼻高流量湿化氧疗常规氧疗脑卒中随机对照试验meta分析

High-flow oxygen through nasal cannulaConventional oxygen therapyStrokeRandomized controlled trialMeta-analysis

《中国医药科学》 2025 (18)

112-116,5

北京市海淀区卫生健康发展科研培育计划(HP2022-98-507003).

10.20116/j.issn2095-0616.2025.18.22

评论